Skip to main content
HNGE logo

HNGE · Hinge Health, Inc. · Documents

Track HNGE — free
$120.95 +5.56 (+4.82%) Play latest call Q3 2026 earnings call transcript
Market Cap
$9.38B
Shares
81.27M
Volume · Nov 16 569.13K Avg daily vol (3M) 1.89M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $587.86M up 50.6% 10-K filed Mar 3, 2026 Quarterly report New FY2026 Q3 Revenue $234.97M up 52.4% 10-Q filed Nov 9, 2026 Latest results Revenue up 52%, full-year guidance raised 8-K filed Nov 2, 2026 Earnings call Q3 2026 earnings call Held Nov 2, 2026
2026
Nov 9
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 51% as nine-month net income turns positive

Hinge Health reported nine-month revenue growth of 51%, primarily from existing clients, and net income of 136,217 (in thousands) versus a loss of 560,356 (in thousands).

Revenue $234.97M ▲ 52.4% Net income $57.4M Diluted EPS $0.66
Read from the MD&A section
4 source passages
Hinge Health leverages software, including AI, to automate care for joint and muscle health, migraine, and gastrointestinal (GI) conditions, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients. Revenue for the nine months ended September 30, 2026 increased by $213.0 million, or 51%, compared to the nine months ended September 30, 2025. The increases were primarily due to revenue growth from existing clients. | Net income (loss) | 57,398 | (1,844) | 136,217 | (560,356) | Open the document at this passage
Nov 2
Earnings call
Q3 2026 earnings call

Hinge Health reported Q3 revenue of $235 million, up 52%, and raised 2026 revenue guidance to $879 million to $881 million. Jim Pursley will step down as president at year-end and join the board.

Read from the first part of this long document
Nov 2
Current report 8-K Events of Oct 29
Revenue up 52%, full-year guidance raised

Hinge Health, Inc. reported third-quarter revenue of $235.0 million, up 52% year-over-year, and raised full-year 2026 revenue guidance to between $879 million and $881 million; non-GAAP operating margin guidance is 30% at the midpoint.

Financial results, Director or officer change, or executive pay, Regulation FD disclosure Read from the first part of this long document
3 source passages
Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. Revenue increased 52% year-over-year to $235.0 million compared to revenue of $154.2 million in Q3 2025. Full Year 2026: We are raising our revenue guidance to be between $879 million and $881 million, reflecting year-over-year growth of 50% at the midpoint. We are raising our non-GAAP income from operations guidance to be between $266 million and $268 million, reflecting year-over-year growth of 123% and non-GAAP operating margin of 30% at the midpoint, a ~1,000 bps increase over 2025. Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $212.82M ▲ 53.0% Net income $43.69M Diluted EPS $0.52
May 7
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $182.31M ▲ 47.2% Net income $35.13M ▲ 105.0% Diluted EPS $0.41 ▼ 68.7%
Apr 17
Proxy statement DEF 14A Meeting Jun 3, 2026
Proxy statement AI summary on its way
Mar 3
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $587.86M ▲ 50.6% Net loss $528.26M Diluted EPS -$7.77
2025
Showing 1–35 of 35 documents
Key facts CIK 1673743 CUSIP 433313103 13F (30d) 248 filings 245 filers Visit website Investor relations